Wei-Shan Chen

Prof. Wei-Shan Chen


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2008 in Molecules
Verified
Journal Article
Open access
PDF file
NZNing Zhang
Ning Zhang
YYYing Yin
Ying Yin
SXSheng-Jie Xu
Sheng-Jie Xu
WCWei-Shan Chen
Wei-Shan Chen
The purpose of this work is to review the published studies on the mechanisms of action and resistance of 5-fluorouracil. The review is divided into three main sections: mechanisms of anti-tumor action, studies of the resistance to the drug, and procedures for the identification of new genes involved in resistance with microarray techniques. The details of the induction and reversal of the drug resistance are also described.

1 March 2010 in Medical Hypotheses
Verified
Journal Article
Closed access
NZNing Zhang
Ning Zhang
FLFang-Cai Li
Fang-Cai Li
YHYi-Jiang Huang
Yi-Jiang Huang
CTChong Teng
Chong Teng
WCWei-Shan Chen
Wei-Shan Chen

27 September 2010 in Molecules
Verified
Journal Article
Open access
PDF file
YWYong-Ping Wu
Yong-Ping Wu
WCWei-Shan Chen
Wei-Shan Chen
YYYing Yin
Ying Yin
NZNing Zhang
Ning Zhang
Neurodegenerative diseases are characterized by neurodegenerative changes or apoptosis of neurons involved in networks, leading to permanent paralysis and loss of sensation below the site of the injury. Cell replacement therapy has provided the basis for the development of potentially powerful new therapeutic strategies for a broad spectrum of human neurological diseases. In recent years, neurons and glial cells have successfully been generated from stem cells, and extensive efforts by investigators to develop stem cell-based brain transplantation therapies have been carried out. We review here notable previously published experimental and preclinical studies involving stem cell-based cell for neurodegenerative diseases and discuss the future prospects for stem cell therapy of neurological disorders in the clinical setting. Steady and solid progress in stem cell research in both basic and preclinical settings should support the hope for development of stem cell-based cell therapies for neurological diseases.

17 February 2010 in The Anatomical Record
Verified
Journal Article
Open access
PDF file
NZNing Zhang
Ning Zhang
JWJohannes Wimmer
Johannes Wimmer
SQSheng‐Jun Qian
Sheng‐Jun Qian
WCWei-Shan Chen
Wei-Shan Chen
Spinal cord injury (SCI) invariably results in the loss of neurons and axonal degeneration at the lesion site, leading to permanent paralysis and loss of sensation. There has been no successful treatment for severe spinal cord injuries to recover back to normal function yet. Studies have shown that the transplantation of stem cells may provide an effective treatment for SCI because of the self‐renewing and multipotential nature of these cells. Stem cells have the capability to repair injured nervous tissue through replacement of damaged cells, neuroprotection, or the creation of an environment conducive to regeneration by endogenous cells. Up to today several types of stem cells have been transplanted into the injured spinal cord. However, the question of which cell type is most beneficial for SCI treatment is still unresolved. There are still several limitations to the current data sets which require further investigation. Anat Rec, 2010.